A summary of novelties and changes 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

From the beginning, we declared war on sudden cardiac death. We have done so over more than four decades in which the constants have been our experience and our perpetual search for innovation.

The objective of the study was to estimate the rate in which COVID-19 patients had heart abnormalities and determine the association between detected abnormalities, their severity, and mortality of the disease.

2020 was a year of uncertainty due to COVID-19. In 2021 we are still confronting uncertainty and the challenges of limitations on so many things, but saving lives must not be one of them. 

Over the past few years, Schiller Americas has been a proud partner of the American Heart Association, an a...

Congenital Heart Defect (CHD) is also known as Congenital Heart Disease (CHD). However, the American Heart Association considers the term “defect” more accurate.